675 West Kendall Street
CRISPR Therapeutics is a leading gene editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene editing platform. CRISPR is a revolutionary technology that allows for precise, directed changes to genomic DNA. The Company’s multi-disciplinary team of world-class researchers and drug developers is working on a number of wholly-owned programs to treat serious diseases with high unmet need.
Founders: Rodger Novak, Emmanuelle Charpentier, Shaun Foy
Scientific Founders: Chad Cowan, Daniel Anderson, Stephen Elledge, Craig Mello, Matthew Porteus
CEO and Co-founder: Rodger Novak
CFO: Marc Becker
CSO (Scientific): Sven Ante (Bill) Lundberg
Please click here for CRISPR Therapeutics job opportunities.
FOLLOW CRISPR THERAPEUTICS: